MedPath

Predicting survival after veno-arterial extra corporeal membrane oxygenation (VA-ECMO) in the context of cardiac surgery.

Not Applicable
Conditions
Shock
Extra corporeal membrane oxygenation
Survival
Cardiac surgery
Cardiovascular - Other cardiovascular diseases
Anaesthesiology - Other anaesthesiology
Registration Number
ACTRN12619001160123
Lead Sponsor
Dr Raymond Hu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
64
Inclusion Criteria

Requiring veno-arterial extra-corporeal membrane oxygenation (VA-ECMO)
Post cardiotomy initiation of VA-ECMO
Adults (>18 years old)

Exclusion Criteria

Transfer to another facility whilst on VA-ECMO
Institution of VA-ECMO prior to cardiopulmonary bypass

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival to hospital discharge or 30 days after VA-ECMO initiation. This will be assessed using the medical records and from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZCTS) database.[Discharge or 30 days after VA-ECMO initiation.];Proportion of patients with successful decannulation (i.e. the ability to remove ECMO cannulae at least once). This will be assessed using the medical records and from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZCTS) database.[Discharge or 30 days after VA-ECMO initiation.];Proportion of patients with pooled major complications within 30 days of ECMO initiation: cannulation site bleeding, limb ischaemia, retroperitoneal haematoma, inadequate oxygenation, transfusion of four or more red blood cells, return to theatre. These will be assessed using the medical records and from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZCTS) database.[Discharge or 30 days after VA-ECMO initiation. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath